IDRx
Branding a Patient-First Future
OverView
IDRx was founded with a singular mission: to redefine the treatment of genetically-driven cancers. Their vision is to make these cancers manageable chronic conditions for millions of people. This patient-first belief drives the development of their lead drug candidate, IDRX-42, and drove the decisions we made together while building their brand and website.
IDRx came to us well-prepared, bringing a clear decision-making process that allowed for swift, decisive action. This empowered our team to execute bold ideas quickly. In a highly streamlined process, they embraced a two-step rebrand: an initial mini refresh to lock in the foundational elements they needed for their pitch deck followed by a broader launch of the fully-developed brand identity and website. Their openness to iterative changes ensured we could refine on the fly, shaping a final product that truly reflects IDRx’s evolving vision.
Our Role
- Brand strategy
- Brand identity
- UX/UI Design
- WordPress development
- Collateral
- Brand Guidelines
Industry
- Biotech & Life Science
Visually, we employed Swiss poster influences—clean lines, bold minimalism, and intuitive layout—to give the site a polished yet approachable feel. We paired this with human-centered messaging and simplified scientific explanations to keep it accessible for patients, caregivers, clinicians, and investors alike. By focusing on IDRx-42’s potential, we aimed to pique curiosity and establish immediate credibility. This purposeful simplicity invites deeper engagement from a broad audience.

For IDRx, the brand and website serve as an authentic platform to champion their patient-first approach and groundbreaking IDRX-42. (And we are delighted to share more news about IDRx here!) For us, it was a collaboration defined by agility, shared enthusiasm, and a commitment to delivering a powerful story—one that underscores the promise of making cancer care more hopeful and human.


Get In Touch
We are full of ideas, we just need someone to share them with.

